Download eBook for Free

FormatFile SizeNotes
PDF file 1.9 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Psychiatrists, nurse practitioners, and other clinicians who work in mental health settings are in an optimal position to treat co-occurring opioid use and mental health disorders (COD-opioid). The U.S. Food and Drug Administration has approved buprenorphine, naltrexone, and methadone as treatments for opioid use disorder. Of these drugs, buprenorphine/naloxone, buprenorphine, and naltrexone extended-release injectable suspension are available outside federally certified opioid treatment programs and are appropriate for use in mental health settings to treat mental health clients with COD-opioid and enhance the effectiveness of mental health treatment.

This guide prepares mental health practitioners to (1) identify clients with co-occurring opioid use and mental health disorders in mental health settings and (2) treat these clients with an appropriate opioid use disorder medication. It provides a practical strategy for treating clients in mental health settings with buprenorphine/naloxone or naltrexone extended-release injectable suspension.

Research conducted by

This research was funded by the National Institute on Drug Abuse (Grant No. 5R34DA046950-02) and carried out within the Access and Delivery Program in RAND Health Care.

This report is part of the RAND Corporation Tool series. RAND tools may include models, databases, calculators, computer code, GIS mapping tools, practitioner guidelines, web applications, and various toolkits. All RAND tools undergo rigorous peer review to ensure both high data standards and appropriate methodology in keeping with RAND's commitment to quality and objectivity.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.